156 related articles for article (PubMed ID: 27378518)
41. Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B-cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms.
Gao Q; Yellapantula V; Fenelus M; Pichardo J; Wang L; Landgren O; Dogan A; Roshal M
Mod Pathol; 2018 Jun; 31(6):881-889. PubMed ID: 29403080
[TBL] [Abstract][Full Text] [Related]
42. Immunoglobulin M concentration in Waldenström macroglobulinemia: correlation with bone marrow B cells and plasma cells.
de Tute RM; Rawstron AC; Owen RG
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):211-3. PubMed ID: 23523273
[TBL] [Abstract][Full Text] [Related]
43. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration.
Nadav L; Katz BZ; Baron S; Yossipov L; Polliack A; Deutsch V; Geiger B; Naparstek E
Br J Haematol; 2006 Jun; 133(5):530-2. PubMed ID: 16681641
[TBL] [Abstract][Full Text] [Related]
44. Multiple myeloma or lymphoma? The increasing role of flow cytometry and serum-free light chain assay.
Mallik N; Nampoothiri RV; Sreedharanunni S; Singh Sachdeva MU; Malhotra P; Varma N
Indian J Pathol Microbiol; 2018; 61(1):149-150. PubMed ID: 29567910
[No Abstract] [Full Text] [Related]
45. Epstein-Barr virus-driven bone marrow aplasia and plasmacytosis mimicking a plasma cell neoplasm.
Desborough MJ; Grech H
Br J Haematol; 2014 May; 165(3):272. PubMed ID: 24405048
[No Abstract] [Full Text] [Related]
46. Plasma cell leukemia mimicking acute myeloid leukemia.
Moore EM; Roth CG
Blood; 2016 May; 127(19):2359. PubMed ID: 28092885
[No Abstract] [Full Text] [Related]
47. Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients.
Paiva B; Vidriales MB; Pérez JJ; Mateo G; Montalbán MA; Mateos MV; Bladé J; Lahuerta JJ; Orfao A; San Miguel JF; ;
Haematologica; 2009 Nov; 94(11):1599-602. PubMed ID: 19880781
[TBL] [Abstract][Full Text] [Related]
48. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
49. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
[TBL] [Abstract][Full Text] [Related]
50. Diagnosis and risk stratification in multiple myeloma.
van de Donk NW; Sonneveld P
Hematol Oncol Clin North Am; 2014 Oct; 28(5):791-813. PubMed ID: 25212883
[TBL] [Abstract][Full Text] [Related]
51. Clear cell myeloma artefactual or real.
Pandey V; Khatib Y; Khade AL; Pandey R; Khare MS
Indian J Pathol Microbiol; 2018; 61(1):159-161. PubMed ID: 29567916
[No Abstract] [Full Text] [Related]
52. Toward development of a novel NOD/SCID-based in vivo strategy to model multiple myeloma pathogenesis.
Bueno C; Lopes LF; Greaves M; Menendez P
Exp Hematol; 2007 Oct; 35(10):1477-8. PubMed ID: 17681665
[No Abstract] [Full Text] [Related]
53. MUC1 (EMA) expressing plasma cells in bone marrow infiltrated by plasma cell myeloma.
Baldus SE; Palmen C; Thiele J
Histol Histopathol; 2007 Aug; 22(8):889-93. PubMed ID: 17503346
[TBL] [Abstract][Full Text] [Related]
54. Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma.
Johnsen HE; Bøgsted M; Klausen TW; Gimsing P; Schmitz A; Kjaersgaard E; Damgaard T; Voss P; Knudsen LM; Mylin AK; Nielsen JL; Björkstrand B; Gruber A; Lenhoff S; Remes K; Dahl IM; Fogd K; Dybkaer K; ;
Cytometry B Clin Cytom; 2010 Sep; 78(5):338-47. PubMed ID: 20533391
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
56. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
Joshi R; Horncastle D; Elderfield K; Lampert I; Rahemtulla A; Naresh KN
J Clin Pathol; 2008 Feb; 61(2):213-6. PubMed ID: 17526802
[TBL] [Abstract][Full Text] [Related]
57. Vortex-dislodged cells from bone marrow trephine biopsy yield satisfactory results for flow cytometric immunophenotyping.
Bommannan K; Sachdeva MU; Gupta M; Bose P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N
Int J Lab Hematol; 2016 Oct; 38(5):543-9. PubMed ID: 27339905
[TBL] [Abstract][Full Text] [Related]
58. Plasma cells with hairy projections and Auer rod-like inclusions in a patient with multiple myeloma.
Sharma P; Sachdeva MUS; Ahluwalia J; Malhotra P
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28775092
[No Abstract] [Full Text] [Related]
59. Quantitation of monoclonal plasma cells in bone marrow biopsies in plasma cell dyscrasia.
Markey GM; Kettle P; Morris TC; Connolly N; Foster H
Anal Cell Pathol; 2003; 25(4):167-71. PubMed ID: 14501083
[TBL] [Abstract][Full Text] [Related]
60. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
